SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-15-007108
Filing Date
2015-08-12
Accepted
2015-08-12 16:21:10
Documents
10
Period of Report
2015-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q mstx-10q_20150630.htm 10-Q 1179939
2 EX-31.1 mstx-ex311_2015063011.htm EX-31.1 13589
3 EX-31.2 mstx-ex312_201506308.htm EX-31.2 13628
4 EX-32.1 mstx-ex321_201506306.htm EX-32.1 9541
  Complete submission text file 0001564590-15-007108.txt   4005752

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT mstx-20150630.xml EX-101.INS 705079
6 XBRL TAXONOMY EXTENSION SCHEMA mstx-20150630.xsd EX-101.SCH 39447
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE mstx-20150630_cal.xml EX-101.CAL 31237
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE mstx-20150630_def.xml EX-101.DEF 90491
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE mstx-20150630_lab.xml EX-101.LAB 264162
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mstx-20150630_pre.xml EX-101.PRE 197735
Mailing Address 3611 VALLEY CENTRE DRIVE SUITE 500 SAN DIEGO CA 92130
Business Address 3611 VALLEY CENTRE DRIVE SUITE 500 SAN DIEGO CA 92130 8585520866
Mast Therapeutics, Inc. (Filer) CIK: 0001160308 (see all company filings)

IRS No.: 841318182 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-32157 | Film No.: 151047259
SIC: 2834 Pharmaceutical Preparations